English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine MedTech
現代牙科集團2025年中期淨利潤升34.7%
Aug 29, 2025 09:25 HKT
Modern Dental Group Reports 34.7% Surge in 1H2025 Net Profit
Aug 29, 2025 09:25 HKT
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
Aug 19, 2025 15:00 HKT
康哲药业(867.HK,8A8.SG)上半年营收净利双升 战略转型跑出增长新动能
Aug 19, 2025 11:53 HKT
康哲藥業(867.HK,8A8.SG)上半年營收淨利雙升 戰略轉型跑出增長新動能
Aug 19, 2025 11:53 HKT
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 11:27 HKT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT
康灃生物中期業績創紀錄 呼吸介入產品驅動收入激增162%
Aug 11, 2025 10:41 HKT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 11, 2025 10:41 HKT
Cornerstone Robotics Completes World's First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery
Aug 06, 2025 19:21 HKT
全球首例!康諾思騰手術機械人完成臨床場景下自主手術驗證
Aug 06, 2025 18:56 HKT
全球首例!康诺思腾手术机器人完成临床场景下自主手术验证
Aug 06, 2025 18:21 HKT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT
維立志博於聯交所主板成功上市
Jul 25, 2025 19:36 HKT
维立志博于联交所主板成功上市
Jul 25, 2025 18:00 HKT
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전
Jul 24, 2025 09:00 HKT
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
Jul 18, 2025 13:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: